Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 11:57 PM ET

Biotechnology

Company Overview of Opexa Therapeutics, Inc.

Executive Profile

Gail J. Maderis

Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee, Opexa Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
58$55,000

Background

Ms. Gail J. Maderis serves as the Chief Executive Officer and President of Bay Area Bioscience Association (formerly, BayBio). Ms. Maderis served as the Chief Executive Officer and President of Five Prime Therapeutics, Inc. until June 18, 2009. Prior to joining FivePrime in July 2003, she spent eleven years at Genzyme Corporation in various business development and general management positions. While at Genzyme, she founded and served as President of Genzyme Molecular ...

Corporate Headquarters

2635 Technology Forest Boulevard
The Woodlands, Texas 77381

United States

Phone: 281-272-9331
Fax: 281-872-8585

Board Members Memberships

2010-Present
Director, Member of Audit Committee and Member of Compensation Committee
2011-Present
Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee

Education

MBA
Harvard Business School
BS
University of California Berkeley

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$15,000
Total Calculated Compensation$55,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
$789.5K
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
--
Weidong Yin Chairman, Chief Executive Officer, President, Managing Director, Secretary, Chairman of Sinovac Hong Kong, Chairman of Tangshan Yian, Chairman of Sinovac Dalian and Director of Sinovac Biotech Co
Sinovac Biotech Ltd.
--
Zhilin Li Chairman, Chief Executive Officer, President and Interim Chief Financial Officer
China Pharma Holdings, Inc.
$225.6K
Guoqing Jiang M.D.Chairman, Chief Executive Officer, President, Acting Chief Financial Officer and Chief Accounting Officer
Tianyin Pharmaceutical Co., Inc.
$100.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Opexa Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.